Carlsmed, Inc.
CARL
NASDAQ·Healthcare·Medical - Devices·Mkt cap $424.1M
$15.60
▲ +0.52%
P/E
-11.47
Mkt Cap
$424.1M
52-Wk Range
$8.50–$17.23
52-Week Range
$8.50 - $17.23
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 16.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary AI and image recognition technology for surgical planning
- Integrated 3D printing capabilities for personalized device manufacturing
- CMS NTAP reimbursement approval reducing market adoption barriers
- Specialized focus on complex adult spinal deformities with high clinical need
Bear Case
1 risk
- Above-average volatility (beta 1.9).
Growth
Moderate growth ahead
Expanding adoption of personalized medicine and precision surgery in orthopedics
Value
Trading at 0.0x Healthcare IT & Services peers — a discount despite the growth profile.
Momentum
Hot
+41.2% over 3m
Quality
Excellent
Emerging growth company (65% revenue growth). Early stage with higher risk.
Dividend
None
No dividend
Smart-money signal
Who's buying CARL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 5, 2026
Reported EPS of -$0.39 vs -$0.40 consensus (+1.5% surprise). Revenue of $18.9M vs $18.0M expected (+5.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+1.5%
Revenue trend · last 8Q
—
+117%
+100%
+99%
+98%
+61%
+58%
+57%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$6.6M
$9.4M
$10.2M
$12.1M
$13.1M
$15.2M
$16.1M
$18.9M
Margins · last 8Q
Gross
76.8%
Operating
-58.3%
Profit
-55.5%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: BTIG · May 6, 2026
vs Industry
How CARL stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related